RNXT short interest
RenovoRx Inc. · Healthcare · Biotechnology · settlement date 2026-09-30
| Shares short | 946,982 |
|---|---|
| Change vs prior report | 273,424 (+40.6%) |
| Change over six months | +59.2% |
| Days to cover | 1.59 (sector: 3.78) |
| Average daily volume | 597,351 |
| Rank in Healthcare | #739 of 922 by days to cover |
RNXT short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 946,982 | +40.6% | 1.59 | 597,351 |
| 2026-09-15 | 673,558 | +55.6% | 1.00 | 2,055,813 |
| 2026-08-31 | 432,726 | -35.8% | 1.00 | 903,872 |
| 2026-08-14 | 674,017 | +137.8% | 1.22 | 553,338 |
| 2026-07-31 | 283,437 | -13.6% | 1.44 | 197,105 |
| 2026-07-15 | 327,868 | -5.2% | 1.68 | 195,541 |
| 2026-06-30 | 345,817 | -1.0% | 1.40 | 246,461 |
| 2026-06-15 | 349,247 | -16.1% | 1.15 | 302,495 |
| 2026-05-29 | 416,166 | +8.4% | 1.22 | 340,257 |
| 2026-05-15 | 384,039 | -24.1% | 1.44 | 265,929 |
| 2026-04-30 | 505,892 | +7.4% | 1.63 | 309,859 |
| 2026-04-15 | 470,946 | -20.8% | 1.62 | 290,609 |
| 2026-03-31 | 594,804 | -3.7% | 1.00 | 643,729 |
| 2026-03-13 | 617,404 | +41.9% | 2.03 | 304,230 |
| 2026-02-27 | 435,099 | -2.0% | 2.74 | 158,843 |
| 2026-02-13 | 444,056 | -20.6% | 2.63 | 168,801 |
| 2026-01-30 | 559,162 | +3.3% | 2.51 | 222,632 |
| 2026-01-15 | 541,448 | +28.9% | 1.14 | 473,407 |
| 2025-12-31 | 419,908 | -5.3% | 2.03 | 206,976 |
| 2025-12-15 | 443,579 | +16.0% | 2.40 | 184,766 |
| 2025-11-28 | 382,383 | -43.5% | 1.33 | 288,370 |
| 2025-11-14 | 676,264 | +7.6% | 1.50 | 451,093 |
| 2025-10-31 | 628,461 | +2.4% | 1.92 | 326,812 |
| 2025-10-15 | 613,527 | +524.4% | 1.00 | 807,035 |
| 2025-09-30 | 98,257 | -64.1% | 1.00 | 654,955 |
import finzdata as yf
yf.Ticker("RNXT").short_interest # every report since 2017
yf.Client().short_interest(["RNXT"], start="2018-01-01")Healthcare short interest · RNXT price history · Who owns RNXT · All short interest